NCT01873469View on ClinicalTrials.gov

Impact of [11C]-Methionine PET/MRI for Individual Tailoring Postoperative Radiochemotherapy for Glioblastoma Multiforme

CompletedOBSERVATIONAL
Enrollment

102

Participants

Timeline

Start Date

July 31, 2013

Primary Completion Date

October 31, 2017

Study Completion Date

October 31, 2018

Conditions
Glioblastoma Multiforme
Interventions
RADIATION

Radiochemotherapy

postoperative radiochemotherapy 60 Gy/ Temozolomide

Trial Locations (1)

01307

Dresden University of Technology, University Hospital Carl Gustav Carus, Department of Radiation Oncology; and DKTK partner site Dresden, Dresden

All Listed Sponsors
lead

Technische Universität Dresden

OTHER

NCT01873469 - Impact of [11C]-Methionine PET/MRI for Individual Tailoring Postoperative Radiochemotherapy for Glioblastoma Multiforme | Biotech Hunter | Biotech Hunter